Laminar specific loss of isocortical presenilin 1 immunoreactivity in Alzheimer's disease. Correlations with the amyloid load and the density of tau-positive neurofibrillary tangles

Neuropathology and Applied Neurobiology

Volumn 26, Issue 2, 2000, Pages 117-123

  Colle, M A ^a   Duyckaerts, C ^a,e   Laquerriere A ^f   Pradier, L ^c   Czech, C ^c   Checler, F ^d   Hauw, J J ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b BICHAT HOSPITAL   (France)

^c SANOFI   (France)

^d INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e Lab Neuropathologie Raymond E   (France)

^f NONE

Author keywords

A peptide; Alzheimer's disease; Familial Alzheimer disease; Morphometry; Presenilin 1; Tau

Indexed keywords

AMYLOID; PRESENILIN 1; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOIDOSIS; ANTIBODIES; CEREBRAL CORTEX; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEURONS; PRESENILIN-1; TAU PROTEINS;

EID: 0034056377     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2000.026002117.x     Document Type: Article

References (23)

1. 1 Barelli H, Lebeau A, Vizzavona J et al. Characterization of new polyclonal antibodies specific for 40 and 42 aminoacids-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol Med 1997; 3: 695-705
2. 2 Buée-Scherrer V, Condamines O, Mourton-Gilles C. AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Mol Brain Res 1996; 39: 79-88
3. 3 Campion D, Brice A, Dumanchin C et al. A novel presenilin 1 mutation in familial Alzheimer's disease with an onset age of 29 years. Neuroreport 1996; 7: 1582-4
4. 4 Campion D, Flaman JM, Brice A et al. Mutations of the presenilin 1 gene in families with early-onset Alzheimer's disease. Hum Mol Genet 1995; 4: 2373-7
5. 5 Delaère P, Duyckaerts C, Brion JP et al. Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type. Acta Neuropathol 1989; 77: 645-53
6. 6 Delesse MA. Procédé mécanique pour déterminer la composition des roches. C R Acad Sci (Paris) 1847; 25: 544
7. 7 Duyckaerts C, Hauw J-J, Bastenaire F et al. Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol 1986; 70: 249-56
8. 8 Duyckaerts C, Llamas E, Delaere P et al. Neuronal loss and neuronal atrophy. Computer simulation in connection with Alzheimer's disease. Brain Res 1989; 504: 94-100
9. 9 Elder GA, Tezapsidis N, Carter J et al. Identification and neuron specific expression of the S182/presenilin 1 protein in human and rodents brain. J Neurosci Res 1996; 45: 308-20
10. 10 Giannakopoulos P, Bouras C, Kövari E et al. Presenilin-1-immunoreactive neurons are preserved in late-onset Alzheimer's disease. Am J Path 1997; 150: 429-36
11. 11 Gomez-Isla T, Hollister R, West H et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997; 41: 17-24
12. 12 Grignon Y, Duyckaerts C, Bennecib M et al. Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease. Acta Neuropathol 1998; 95: 395-406
13. 13 Hendricks L, De Jonghe C, Lübke U. Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain. Exp Neurol 1998; 149: 341-8
14. 14 Kovacs DM, Fausett HJ, Page KJ et al. Alzheimer-associated presenilin1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature (Medicine) 1996; 2: 224-9
15. 15 Lee M, Slunt H, Martin L et al. Expression of presenilin1 and, 1996; 2 (PS1: and PS2) in human and murine tissues. J Neurosci; 16: 7513-25
16. 16 Moussaoui S, Czech C, Pradier L et al. Immunohistochemical analysis of presenilin-1 expression in the mouse brain. FEBS Lett 1996; 383: 219-22
17. 17 Snedecor G, Cochran W. Statistical Methods 7th edition. Ames: Iowa State University Press, 1980
18. 18 The National Institute on Aging and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18: S1-S2
19. 19 Thinakaran G, Borchelt D, Lee M et al. Endoproteolysis of presenilin 1 and accumulation of processed derivates in vivo. Neuron 1996; 17: 181-90
20. 20 Uchihara T, El Hachimi HK, Duyckaerts C et al. Widespread immunoreactivity of presenilin in neurons of normal and Alzheimer's disease brains: Double-labeling immunohistochemical study. Acta Neuropathol 1996; 92: 325-30
21. 21 Weibel E. Stereological Methods Volume 1. New York. Academic press, 1979
22. 22 Wisniewski T, Palha JA, Ghiso J et al. S182 in Alzheimer's disease neuritic plaques. Lancet 1995; 346: 1366
23. 23 Xia W, Xhang J, Ostaszewski BL et al. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi. Biochem 1998; 47: 16465-71